Search PubMed⌕ Search

Biomedical subjects

J Kopecek

Publications and source records attributed to J Kopecek.

132 records · Page 8Linked to original sources

Enantioselective release of 5-fluorouracil from N-(2-hydroxypropyl)methacrylamide-based copolymers via lysosomal enzymes.

Water soluble copolymers based on N-(2-hydroxypropyl)methacrylamide (HPMA) containing oligopeptide side chains terminated in an alpha-substituted glycine derivative of the anticancer compound 5-fluorouracil (5-FU) were synthesized by a new facilitated synthetic route and studied for their ability to release free 5-FU in the presence of lysosomal enzyme preparations. In addition, the properties of the low molecular weight alpha-substituted glycine derivatives were studied in the presence of lysosomal enzyme preparations and leucine aminopeptidase. The results revealed that (1) the stereochemistry (L vs D) of the alpha-substituted glycine derivative, (2) the hydrophobicity (Ala vs Leu) of the penultimate amino acid residue relative to the alpha-substituted glycine derivative, and (3) the total length of the oligopeptide sequence spacer (tetrapeptide vs hexapeptide) terminated in the alpha-substituted glycine derivative and the polymer carrier all directly influence the enzymatically catalyzed release of free 5-FU.

Amino Acid Sequence↗

Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells.

N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers containing pendant saccharide moieties (galactosamine, lactose, and triantennary galactose) were synthesized. The relationship between the content of saccharide moieties and three-dimensional arrangement of galactose residues and their biorecognition and internalization by human hepatocarcinoma HepG2 cells was investigated. The results obtained clearly indicated preferential binding of the trivalent galactose and the lactose-containing copolymers to these cells. The higher the saccharide moieties content in HPMA copolymers, the higher the levels of binding. The biorecognition of the glycosylated HPMA copolymers by HepG2 cells was inhibited by free lactose. The data on the internalization and subcellular trafficking of HPMA copolymer conjugates obtained by confocal fluorescence microscopy correlated well with the flow cytometric analysis of their biorecognition by target cells. Structural features of the glycosides responsible for the specific recognition of the HPMA copolymers have been identified. The results underline the potential of glycosylated HPMA copolymers for delivery of pharmaceutical agents to hepatocarcinoma cells.

Biological Transport↗

Functionalized semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] for protein modification.

Semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]s (ST-PHPMA) with different functional end groups, namely carboxyl, methyl ester, hydrazide, and amino groups, were prepared by chain transfer free-radical polymerization. 2,2'-Azobisisobutyronitrile (AIBN) was used as an initiator and 3-mercaptopropionic acid, methyl 3-mercaptopropionate, 3-mercaptopropionic hydrazide, and 2-mercaptoethylamine were used as chain-transfer agents. The semitelechelic polymers have been characterized by end-group analysis, size-exclusion chromatography (SEC), and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The effects of the concentrations of the mercaptans and the initiator on the molecular weight of the polymers have been investigated. The higher the concentration of mercaptan, the lower the molecular weight of ST-PHPMA. The concentration of initiator did not have a significant effect on the molecular weight of the semitelechelic polymers. The end groups of the ST polymers can be readily transformed by polymeranalogous reactions. A model protein, alpha-chymotrypsin, has been modified with ST-PHPMA-CONHNH2 and ST-PHPMA-COOSu and the conjugates characterized by MALDI-TOF MS. The activity of modified chymotrypsins toward a high molecular weight substrate, P-Gly-Leu-Phe-NAp (where P is the HPMA copolymer backbone, and NAp is p-nitroanilide), was slightly lower than the activity of the native enzyme. The cleavage of a low molecular weight substrate, Z-Gly-Leu-Phe-NAp, by modified chymotrypsins was dependent on their structure. Whereas the activity of the amino group modified chymotrypsins was higher than that of the native enzyme, the activity of carboxyl-modified chymotrypsins was lower than that of the native enzyme. In summary, the data seem to indicate that ST-PHPMA is an effective protein-modifying agent.

Amines↗

Synthesis of bioadhesive lectin-HPMA copolymer-cyclosporin conjugates.

An amino group containing cyclosporin A (CsA) derivative has been synthesized and conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer via an aromatic azo bond, which can be specifically cleaved by azoreductase activity in colon to release the drug for the treatment of colon diseases. Lectins, peanut (Arachis hypogea) agglutinin (PNA) and wheat germ agglutinin (WGA), have been conjugated to HPMA copolymer-CsA derivative conjugates (PCsA), respectively, to give bioadhesive conjugates. The PNA and WGA are the targeting proteins that can bind to diseased colon tissue and healthy tissue, respectively. There were on average four P(CsA) copolymer chains attached on one WGA molecule with a drug content of 16.0 wt % and five P(CsA) copolymer chains attached on one PNA molecule with a drug content of 11.5 wt %. The incubation of a P(CsA) copolymer with the rat cecal contents resulted in the cleavage of the azo bond and release of the cyclosporin derivative. The biological evaluation of the conjugates is under way.

Adhesives↗

Self-assembled peptides exposing epitopes recognizable by human lymphoma cells.

A bifunctional N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer containing nitrilotriacetic acid (NTA) and benzophenone (BP) groups was synthesized by free-radical copolymerization of HPMA, 2-methacrylamidobutyl nitrilotriacetic acid (MABNTA), and 4-methacrylamido benzophenone (MABP) using 2, 2'-azobisisobutyronitrile (AIBN) as initiator. A His-tagged coiled coil stem loop peptide containing a tridecapeptide (TDP) epitope (GFLGEDPGFFNVE) in the loop region (CCSL-TDP) was designed and synthesized genetically by expressing an artificial gene in Escherichia coli BL21 (DE3). The peptide was characterized by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), size-exclusion chromatography (SEC), and circular dichroism (CD) spectroscopy. Surfaces containing self-assembled CCSL-TDP peptide were prepared by first covalently grafting poly(HPMA-co-MABNTA-co-MABP) onto polystyrene (PS) surface by UV irradiation, then charging the surface with nickel through NTA groups, and finally attaching the CCSL-TDP peptide through Ni-histidine chelation. The modified PS surfaces with and without self-assembled CCSL-TDP peptide were characterized by X-ray photoelectron spectroscopy (XPS) and time-of-flight secondary ion mass spectrometry (TOF-SIMS). Cell attachment studies with human Burkitt's lymphoma Raji B cells showed that the cells selectively bound to the self-assembled CCSL-TDP peptide surfaces, but not to the surfaces of PS, PS with grafted copolymer, and PS with grafted copolymer and self-assembled coiled coil peptide with similar structure but without the epitope. This indicates that the cell attachment was mediated by the CCSL-TDP peptide, most probably by the TDP epitope region. The CCSL peptide self-assembly presented here may represent a feasible model of exposing epitopes for biorecognition studies.

Acrylamides↗

Isobolographic assessment of the interaction between adriamycin and photodynamic therapy with meso-chlorin e6 monoethylene diamine in human epithelial ovarian carcinoma (OVCAR-3) in vitro.

OBJECTIVE: Considering the differing mechanisms of cytotoxicity produced by adriamycin and the photosensitizer meso-chlorin e6 monoethylene diamine (Mce6) with light, the interaction of these agents in combination on human ovarian epithelial carcinoma (OVCAR-3 in vitro) was evaluated by dose and effect addition isobole analysis. METHODS: Mitochondrial respiration via the 3-(4,5-dimethyl thiazol-2 yl)-2,5-diphenyl tetrazolium bromide cleavage assay (MTT) and reproductive capacity via the tritiated thymidine incorporation assay (TI) were assessed 72 and 144 hours after exposure to adriamycin, Mce6, and light (650 nm), and to their combinations, in OVCAR-3 cells grown in vitro (20,000 cells per well). RESULTS: In the majority of assays, reproductive capacity was more sensitive to the drug(s) than was mitochondrial respiration (2-10x). Dose-addition isobole analysis showed synergy for the combination of 50% median effective dose (ED50) adriamycin with 50% ED50 Mce6/light in all assays (all P < or = .027). Antagonism was noted with the combination 25% ED50 adriamycin with 75% ED50 Mce6/light. Additivity and synergy were the predominant interactions for 75% ED50 adriamycin with 25% ED50 Mce6/light by dose-addition isobole analyses. Effect-addition isoboles showed a predominance of synergy, particularly for the combination 50% ED50 adriamycin with 50% ED50 Mce6/light. CONCLUSION: Synergy and additivity are the primary in vitro interactions for the combination of adriamycin and Mce6/light in the dosage range tested. Reproductive capacity is more sensitive to these agents than is mitochondrial respiration.

Cell Division↗